IRIS
COLUCCIA, Mauro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.333
EU - Europa 1.212
AS - Asia 715
OC - Oceania 4
SA - Sud America 1
Totale 7.265
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.326
CN - Cina 631
SE - Svezia 391
UA - Ucraina 197
IT - Italia 193
DE - Germania 161
FI - Finlandia 132
GB - Regno Unito 65
SG - Singapore 29
IN - India 28
BE - Belgio 16
IE - Irlanda 15
FR - Francia 13
IR - Iran 12
CZ - Repubblica Ceca 11
VN - Vietnam 10
RU - Federazione Russa 8
CA - Canada 7
AT - Austria 3
AU - Australia 3
HK - Hong Kong 2
RO - Romania 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CL - Cile 1
LT - Lituania 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PL - Polonia 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 7.265
Salva come PNG Salva come JPEG
Città #
Fairfield 634
Chandler 602
Woodbridge 576
Jacksonville 461
Houston 365
Nyköping 327
Ashburn 320
Seattle 267
Ann Arbor 255
Cambridge 244
Wilmington 211
Nanjing 141
Lawrence 128
Roxbury 128
Bari 126
Beijing 118
New York 109
Des Moines 84
Boardman 81
Princeton 57
Inglewood 55
Nanchang 42
Hebei 39
Helsinki 34
San Diego 32
Shenyang 32
Jiaxing 31
Dearborn 29
Brooklyn 24
Pune 21
Tianjin 19
Los Angeles 18
Guangzhou 17
Brussels 16
Dublin 15
Singapore 14
Ardabil 12
Changsha 12
Brno 11
Shanghai 11
Auburn Hills 10
Dong Ket 10
Kunming 10
Leawood 10
Ningbo 9
Washington 9
Jinan 8
San Francisco 8
San Mateo 8
Wuhan 8
Augusta 7
London 7
Redwood City 7
Wuxi 7
Jinhua 6
Norwalk 6
Paris 6
Taizhou 6
Zhengzhou 6
Hefei 5
Milan 5
Mumbai 5
Toronto 5
Yiwu 5
Hangzhou 4
Baotou 3
Lanzhou 3
Monmouth Junction 3
Santa Marinella 3
Sassari 3
Shenzhen 3
Terlizzi 3
Vienna 3
Berlin 2
Brescia 2
Calci 2
Dongyang 2
Fuzhou 2
Grafing 2
Hong Kong 2
Hounslow 2
Kilburn 2
Melbourne 2
Munich 2
Quanzhou 2
Acton 1
Bacoli 1
Bandar Seri Begawan 1
Bucharest 1
Chiswick 1
Chongqing 1
Christchurch 1
Dalian 1
Edinburgh 1
Falls Church 1
Freiberg 1
Heze 1
Indiana 1
Kathmandu 1
Ljubljana 1
Totale 5.958
Salva come PNG Salva come JPEG
Nome #
The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds 137
Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature 132
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 126
Mutagenic activity of some platinum complexes: chemical properties and biological activity 119
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier 118
Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells. 113
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 107
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 106
Effect of chirality in platinum drugs 106
null 104
Mutagenic activity of some platinum complexes with monodentate and bidentate amines 103
Cell Cycle Regulation by Ca2+-Activated K+ (BK) Channels Modulators in SH-SY5Y Neuroblastoma Cells 103
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 98
Efficacy of 5FU combined to Na[trans-RuCl4(DMSO)Im], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline, and MCa mammary carcinoma 94
Trans-Platinum Compounds in Cancer Therapy: A largely Unexplored Strategy for Identifying Novel Antitumor Platinum Drugs 92
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds [Na]2{trans-RuCl4(Me2SO)]2(µ-L)} (L = ditopic, non-chelating aromatic N-ligand) 90
null 90
null 88
Ruthenium-sulfoxide complexes with a specific antimetastatic activity 87
Antitumor trans-platinum DNA adducts: NMR and HPLC study of the interaction between a trans-Pt(iminoether) complex and the deoxy decamer d(CCTCGCTCTC).d(GAGAGCGAGG) 87
Intelligent microarray data analysis through non-negative matrix factorization to study human multiple myeloma cell lines 87
DNA binding specificity of the antitumor complexes cis- and trans-RuCl2(DMSO)4 determined by primer extension footprinting assay 84
Treatment with cyclosporin A does not affect macrophage procoagulant activity and plasminogen activator inhibitor in mice 80
Platinum(II) based anticancer agents with a trans geometry 79
Endothelial cells in the bone marrow of patients with multiple myeloma 78
Mutagenic activity of transition metal complexes: relation structure-mutagenic and antibacterial activity for some Pd(II), Pt(II) and Rh(I) complexes 77
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 77
Biologic activity of platiunum complexes with proflavine 76
Mutagenic activity of transition metal complexes: relation structure-mutagenic and antibacterial activity for some Pd(II), Pt(II) and Rh(I) complexes 76
Effect of isomerism at non-leaving ligands in platinum anticancer drugs 76
In vitro cisplatin effects on phagocyte functions 76
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 74
Trans-Platinum Complexes in Cancer Therapy 73
Current Status of trans-Platinum Compounds in Cancer Therapy 73
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 71
Biological Activity of Platinum Complexes Containing Chiral Centers on the Nitrogen or Carbon atoms of a Chelate Diamine Ring. Inorg. Chim. Acta, 69
Antitumor active trans-platinum compounds 69
Antitumour platinum iminoether complexes 68
Antitumour platinum-iminoether complexes 68
ANTIBACTERIAL AND ANTICANCER ACTIVITY OF PLATINUM COMPLEXES WITH CHIRAL DIAMINES 68
null 68
null 67
A preclinical overview on gold(III) compounds in the forefront of the targeted anticancer therapy. 66
null 66
Platinum(II)-Acyclovir complexes of acyclovir: synthesis, antiviral and antitumor activity 66
null 65
Biological activity of platinum complexes containing chiral centers on the nitrogen or carbon atoms of a chelate ring. 65
null 65
Pharmacological action of the platinum-iminoether complex cis-[PtCl2{E-HN=C(OMe)}NH3] 63
Salivary up-regulation of human polymorphonuclear leucocyte chemotaxis and adhesion-molecule expression 62
Bone marrow fibroblasts provide a permissive microenvironement for multiple myeloma cells 61
Antitumour platinum iminoether complexes 60
Antitumour activity and matrix metalloproteinase inhibition by platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 59
Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline 59
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 59
DIFFERENT BINDING TO DNA OF ENANTIOMERIC PLATINUM COMPLEXES ASSESSED BY INHIBITION OF RESTRICTION ENZYME-ACTIVITY 58
A Framework for Biological Data Normalization, Interoperability, and Mining for Cancer Microenvironment Analysis 58
Bone marrow fibroblasts provide a permissive microenvironment for multiple myeloma cells. 57
Leading-edge gold(III) derivatives in targeted anticancer therapy: in vivo acute toxicity investigation and transcriptomic analysis of treatment-induced response in two human breast cancer cell lines. 57
Antitumour ruthenium(II)-dimethylsulfoxide complexes 57
Antitumor trans iminoether platinum di- and oligonucleotide adducts studied by NMR. 56
null 55
null 55
Effect of antitumor platinum compounds with trans geometry on the induction of cytotoxicity and cell cycle modifications 54
Anttitumor activity of trans-platinum species 54
Antitumor activity of trans platinum complexes 54
null 53
null 52
Platinum complexes with bisphosphonate analogue: a novel dual mechanism of antitumour action 51
Bone Marrow Fibroblasts and Multiple Myeloma Progression 51
null 51
Water soluble ruthenium(III)-dimethylsulfoxide complexes: chemical behavior and pharmacological properties 50
CITOTOSSICITA' IN VITRO DI ALCUNI MATERIALI DENTALI 49
Inibizione di metalloproteasi da parte di complessi di platino con analoghi bisfosfonati 49
Salivary up-regulation of PMN chemotaxis and adhesion molecules expression 47
Na[trans-RuCl4(DMSO)Im]2DMSO: antimetastatic ruthenium 46
Identification of genes associated with platinum iminoether compounds activity in ovarian cancer cells 46
Interaction of RuCl2 (dimethylsulphoxide)4 isomers with DNA 46
Analisi dell’espressione genica (Dna Microarray) in cellule endoteliali e cellule tumorali dopo trattamento con il farmaco antimetastatico sperimentale Nami-A 45
Ulteriori contributi allo studio dell'interazione cisplatino-DNA 44
MMP activity inhibition by platinum-diethyl[(methylsulfinyl)methyl]phosphonate (SMP) complexes” 44
Cellular and biochemical properties of antitumour trans platinum-iminoether complexes 44
Antiviral and antitumour properties of a platinum(II) complex with acyclovir 43
Inhibition of endothelial cell function and angiogenesis by the metastasis inhibitor NAMI-A 43
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 42
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 41
Effects of trans-[PtCl2(NH3){Z-HN=C(OMe)Me}] (trans-Z) and Transplatin on cell-cycle progression and gene expression of SVOK-3 ovarian cancer cells 41
DNA adducts of antitumor trans-[PtCl2(E-imimo ether)2] 40
Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy 40
Bone Marrow Fibroblasts and Multiple Myeloma Progression. 39
Complessi antitumorali di platino a geometria trans 38
Trans platinum complexes in cancer therapy: a largely unexplored strategy of identifying novel antitumour platinum drugs 37
Method for synthesizing complexes of platinum with iminoethers and their use as antitumoral drugs and nucleotide base modifiers 37
Response of MCa mammary carcinoma to cisplatin and to Na(trans- Rucl4(DMSO)Im): Selective inhibition of spontaneous lung metastases by the ruthenium complex. 37
DNA modifications by antitumor trans-[PtCl2(E-iminoether)2] 37
Inhibition of matrix metallo proteinase activity by novel platinum complexes with bisphosphonate analogues 36
Platinum complexes with cyclic ligands mimicking iminoether species, synthesis and biological activity 36
Mutagenic activity of some paltinum complexes: Chemical properties and biological activity 34
null 33
null 33
Totale 6.620
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.309
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.309
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.360 0 98 46 137 160 92 179 119 181 93 228 27
2020/20211.276 150 49 151 48 137 65 75 90 156 177 123 55
2021/2022787 21 121 1 30 32 33 32 35 44 49 156 233
2022/20231.524 217 144 123 145 196 202 6 194 233 11 22 31
2023/2024565 40 87 25 27 69 183 4 35 12 10 1 72
2024/2025163 138 25 0 0 0 0 0 0 0 0 0 0
Totale 7.565